CLINICAL ROLE -
Clinical Overview: Teprotumumab for Thyroid Eye Disease
Teprotumumab is the first fully human IgG1 monoclonal antibody approved by the FDA for the treatment of thyroid eye disease at its source not just reducing the symptoms.
Read More